Skip to content

Mary Cannon

4 papers in the library · 1,006 citations · publishing 2004-2026

Papers

Sort Most recent Most cited

Using AI to Detect Psychosis Relapse: Scoping Review.

JMIR Ment Health June 16, 2026 Lorenzo Ghelfi, Jack Healy, Francesco Piacenza et al.

Abstract Background Psychotic disorder represents a leading cause of disability worldwide, and relapse in psychosis is common. Artificial intelligence (AI) is increasingly recognized as a method that could aid clinical monitoring for individuals experiencing psychosis. Objective This review aims to map the existing literature on AI-based approaches—including machine learning, deep learning, and...

Chronic adolescent exposure to Δ-9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology October 2010 Colm M P O'Tuathaigh, Magdalena Hryniewiecka, Aine Behan et al.

Cannabis use confers a two-fold increase in the risk for psychosis, with adolescent use conferring even greater risk. A high-low activity catechol-O-methyltransferase (COMT) polymorphism may modulate the effects of adolescent Δ-9-tetrahydrocannabinol (THC) exposure on the risk for adult psychosis. Mice with knockout of the COMT gene were treated chronically with THC (4.0 and 8.0 mg/kg over 20...

Psychotic symptoms in the general population – an evolutionary perspective

The British Journal of Psychiatry August 31, 2010 Ian Kelleher, Jack A. Jenner, Mary Cannon 82 citations

Our ideas about the intrinsically pathological nature of hallucinations and delusions are being challenged by findings from epidemiology, neuroimaging and clinical research. Population-based studies using both self-report and interview surveys show that the prevalence of psychotic symptoms is far greater than had been previously considered, prompting us to re-evaluate these psychotic symptoms...

Causal association between cannabis and psychosis: examination of the evidence

The British Journal of Psychiatry January 30, 2004 Louise Arseneault, Mary Cannon, John Witton et al. 924 citations

BACKGROUND: Controversy remains as to whether cannabis acts as a causal risk factor for schizophrenia or other functional psychotic illnesses. AIMS: To examine critically the evidence that cannabis causes psychosis using established criteria of causality. METHOD: We identified five studies that included a well-defined sample drawn from population-based registers or cohorts and used prospective...